Phase INeuropeptide
Compound 62016
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-062016
Risk Class
HIGH
Last Audit
Nov 24, 2108
Research Abstract
Neuropeptide candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 62016 is a neuropeptide asset inside neuropeptide innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in phase i with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-062016 with updates logged 2108-11-24.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-62016Neuropeptide Program 62016
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-062016
- [2] Operations Pulse • Neuropeptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-62016